Tag: Eli

Mumbai: Eli Lilly is confident of sustained demand for its weight-loss and anti-diabetes drug despite premium pricing amid the imminent launch of cheaper semaglutide generics in the Indian market.The ...

“With this approval, all six dosage options for Mounjaro (tirzepatide) will soon be available in India, supporting a more personalised approach to treatment and allowing healthcare professionals to tailor ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's ...

Mumbai: Eli Lilly, the world's most-valued drugmaker that seeks to shake up India's lifestyle disease management through its recent introduction of weight-loss injectable Mounjaro, is working on a potential ...

Pharma major Lupin Ltd on Monday said it has acquired anti-diabetic medicine 'Huminsulin' in India from Eli Lilly and Company for an undisclosed sum to further enhance its diabetes ...

Eli Lilly, a US-based pharmaceutical company renowned for its weight-loss treatments, announced plans to introduce its flagship drug, Tirzepatide, to the Indian market in 2025. The drug, marketed under ...

The government, in this year’s Union Budget, has focused on the new Employment-Linked Incentive Scheme under which it has listed a number of policies to increase the number of ...

Alphabet has announced who its new chief financial officer (CFO) will be, revealing today that it has hired pharmaceutical giant Eli Lilly and Company’s CFO Anat Ashkenazi. Ashkenazi will ...

Hyderabad: U.S. drugmaker Eli Lilly expects to launch Mounjaro, its blockbuster diabetes drug and a wildly popular obesity treatment, in India as early as next year, CEO David Ricks ...